Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Callan Jmb (CJMB) Capital Expenditures (2024 - 2025)

Callan Jmb (CJMB) has disclosed Capital Expenditures for 2 consecutive years, with $169390.0 as the latest value for Q3 2025.

Quarterly Capital Expenditures rose 57712.29% to $169390.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $616896.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $46167.0 for FY2024, 90.58% down from the prior year.
Capital Expenditures hit $169390.0 in Q3 2025 for Callan Jmb, down from $432506.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $432506.0 in Q2 2025 to a low of $293.0 in Q3 2024.